Xinyi Wang
Xinyi Wang
Vaccines have always been a critical tool in preventing infectious diseases. However, the development of traditional vaccines often takes a long time and may struggle to address the challenge of rapidly mutating viruses. The emergence of mR...
Unveiling Immunological and Hematological Markers in COVID-19: Insights from a Clinical Study [0.03%]
COVID-19的免疫和血液学标志物的临床研究进展
Hassan Imran,Muslim Bin Aqeel,Sidra Gull et al.
Hassan Imran et al.
The COVID-19 pandemic has affected the global health system and economies largely. Therefore, knowledge about the clinical and laboratory profiles of patients with COVID-19 would help in the management and prognosis of the disease. The immu...
The Effects of Severe Symptoms of SARS-CoV-2 Infections on the Anti/Proapoptotic Molecules: A 6-Month Cohort Study [0.03%]
SARS-CoV-2感染重症对抗凋亡和促凋亡分子的影响：一项为期六个月的队列研究
Masoud Karimi-Googheri,Zahra Madjd,Jafar Kiani et al.
Masoud Karimi-Googheri et al.
The plausible effects of SARS-CoV-2 infection on the expression of anti/proapoptotic molecules have been suspected. This cohort study examined the expression of p53, Bcl-2, Bid, Bak, and Bax molecules, the genes associated with induction or...
An Hoai Duong,Giang Thi Nguyen,Hien Thi Vu et al.
An Hoai Duong et al.
The current study investigates COVID-19 infection likelihood using data from 5,819 respondents in Vietnam and Indonesia (December 10, 2022, to March 27, 2023) through binary logistic regressions. Descriptive statistics highlight the signifi...
Investigation of SARS-CoV-2 IgG Binding Capability to Variants of the SARS-CoV-2 Virus [0.03%]
SARS-CoV-2变异病毒的SARS-CoV-2 IgG结合能力调查研究
Lucy Johnson,Cillian F De Gascun,Jaythoon Hassan
Lucy Johnson
The SARS-CoV-2 pandemic has confirmed that the ability to rapidly mutate may be extremely beneficial for a virus. Not long after the first wave, new variants emerged with altered infectivity, disease severity, and mortality. These new strai...
Ascorbic Acid and α-Tocopherol in the Inactivated SARS-CoV-2 Vaccine Formulation: Induction of the Th1 Pattern in Aged Mice [0.03%]
抗坏血酸和α-生育酚在灭活新冠病毒疫苗中的作用：诱导老年小鼠的Th1模式反应
Nika Asefi,Parviz Pakzad,Akbar Khorasani et al.
Nika Asefi et al.
Aging is physiologically associated with a decline in the function of the immune system and subsequent susceptibility to infections. Interferon-gamma (IFN-γ), a key element in the activation of cellular immunity, plays an important role in...
An Overview of the Types of Adjuvants Used in the Vaccination Industry And Their Mechanisms of Action [0.03%]
疫苗行业中所用佐剂的类型及其作用机制概述
Nemat Shams,Amin Jaydari,Hamideh Najafi et al.
Nemat Shams et al.
The widespread use of efficient vaccines against infectious diseases is regarded as one of the most significant advancements in public health and techniques for preventing and protecting against infectious diseases and cancer. Because the p...
Nathalie Ghorra,Alexandros Popotas,Tatiana Besse-Hammer et al.
Nathalie Ghorra et al.
The enduring impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its disease manifestation, COVID-19, on public health remains significant. Postacute sequelae of SARS-CoV-2 infection (PASC) affect a considerable numbe...
Comparison of Adverse Events and Antibody Responses Among Different COVID-19 Vaccination Schedules [0.03%]
不同新冠疫苗接种程序的不良事件及抗体反应比较分析
Ana Carolina M Dinelly Pinto,Maria Francilene S Silva,Fátima de Cássia E de Oliveira et al.
Ana Carolina M Dinelly Pinto et al.
Global investment in developing COVID-19 vaccines has been substantial, but vaccine hesitancy has emerged due to misinformation. Concerns about adverse events, vaccine shortages, dosing confusion, mixing vaccines, and access issues contribu...
Comparative Study
Viral immunology. 2024 Sep;37(7):337-345. DOI:10.1089/vim.2024.0019 2024
Effective Treatment of COVID-19 Infection with Repurposed Drugs: Case Reports [0.03%]
COVID-19感染的再利用药物有效治疗个案报告
Abraham M Enyeji,Amit Arora,Harpal S Mangat
Abraham M Enyeji
The COVID-19 pandemic response has been hindered by the absence of an efficient antiviral therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The reason why the previous preventative approach to COVID-19 solely through...
Case Reports
Viral immunology. 2024 Aug;37(6):298-307. DOI:10.1089/vim.2024.0034 2024